Multiple-dose pharmacokinetics of intravenously administered cefoperazone and sulbactam when given in combination to infected, seriously ill, elderly patients (Q35305116)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Multiple-dose pharmacokinetics of intravenously administered cefoperazone and sulbactam when given in combination to infected, seriously ill, elderly patients	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Multiple-dose pharmacokinetics of intravenously administered cefoperazone and sulbactam when given in combination to infected, seriously ill, elderly patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Schwartz JI

1

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Jauregui LE

2

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Bachmann KA

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Martin ME

4

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Reitberg DP

5

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

language of work or name

0 references

publication date

1 May 1988

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

730-735

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172261

27 July 2018

Pharmacokinetics of cefoperazone: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172261

27 July 2018

A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172261

27 July 2018

Effect of protein binding on cefmenoxime steady-state kinetics in critical patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172261

27 July 2018

Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172261

27 July 2018

The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172261

27 July 2018

Inhibition kinetics of three R-factor-mediated β-lactamases by a new β-lactam sulfone (CP 45899)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172261

27 July 2018

Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172261

27 July 2018

A rapid, universal TI-59 model-independent pharmacokinetic analysis program based on statistical moment theory.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172261

27 July 2018

Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172261

27 July 2018

Pharmacokinetics and pharmacodynamics of cefoperazone-sulbactam in patients on continuous ambulatory peritoneal dialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172261

27 July 2018

Multiple-dose pharmacokinetics and toleration of intravenously administered cefoperazone and sulbactam when given as single agents or in combination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172261

27 July 2018

Prediction of creatinine clearance from serum creatinine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172261

27 July 2018

Protein binding of antimicrobials: clinical pharmacokinetic and therapeutic implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172261

27 July 2018

Computation of model-independent pharmacokinetic parameters during multiple dosing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172261

26 September 2018

Pharmacokinetics of sulbactam in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172261

26 September 2018

Steady-state moxalactam pharmacokinetics in patients: noncompartmental versus two-compartmental analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/3395103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-dose pharmacokinetics of cefoperazone following intravenous administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/3395103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cefoperazone: pharmacokinetics in humans with normal and impaired renal function and pharmacokinetics in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/3395103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cefoperazone: absorption, excretion, distribution, and metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/3395103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Third generation cephalosporins

1 reference

https://pubmed.ncbi.nlm.nih.gov/3395103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of parenteral sulbactam in patients with appendicitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/3395103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.32.5.730

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35305116&oldid=2143800870"